yohimbine has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; He, Z; Li, ZC; Yang, DD; Zhang, J; Zhao, B | 1 |
| Nakano, T; Okamoto, H | 1 |
2 other study(ies) available for yohimbine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Clonidine ameliorates cerebral ischemia-reperfusion injury by up-regulating the GluN3 subunits of NMDA receptor.
Topics: Animals; Brain Ischemia; Clonidine; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Yohimbine | 2022 |
Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Dexmedetomidine; Hypnotics and Sedatives; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vascular Resistance; Yohimbine | 2009 |